10 Stocks Moving In Friday's Pre-Market Session

Gainers

• Eleven Biotherapeutics Inc EBIO shares rose 42.9 percent to $2.80 in pre-market trading after the company reported the effectiveness of IND application for EBI-031.
• Mitel Networks Corporation MITL rose 22.1 percent to $7.35 in pre-market trading as Polycom reported an end of Mitel merger deal.
• Barracuda Networks Inc CUDA shares rose 15.7 percent to $17.94 in pre-market trading as the company reported stronger-than-expected results for its first quarter. The company reported that CFO David Faugno will be stepping down and current chief accounting officer, Dustin Driggs, will replace Faugno.
• Polycom Inc PLCM shares rose 13.6 percent to $12.35 in pre-market trading after the company revealed Friday that private equity firm, Siris Capital Group, LLC and its affiliates, have submitted a unilaterally binding offer to buy all outstanding shares for $12.50 per share in cash.
• Smith & Wesson Holding Corp SWHC shares rose 5 percent to $29.70 in pre-market trading. Gun manufacturers shares rose after a deadly shooting in downtown Dallas. Three people were in custody while a fourth suspect exchanged gunfire with police authorities. A sniper fatally shot 11 officers, five fatally.
• Gap Inc GPS rose 3.6 percent to $22.40 in pre-market trading. Gap reported a 2 percent rise in its comparable sales for June, while total sales increased to $1.57 billion from $1.54 billion.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Juno Therapeutics Inc JUNO shares fell 26.2 percent to $30.12 in pre-market trading after the company announced JCAR015's Phase 2 trial was put on hold after two patients died last week.
• Kite Pharma Inc KITE shares dipped 7.9 percent to $48.00 in pre-market trading after Juno Therapeutics reported an FDA clinical hold on JCAR015's Phase 2 trial.
• WD-40 Company WDFC shares tumbled 4.2 percent to $111.10 in the pre-market trading session. WD-40 reported upbeat earnings for its third quarter on Thursday. However, the company posted weaker-than-expected sales and lowered its revenue outlook for the year.
• Galena Biopharma Inc GALE fell 2.6 percent to $0.501 in pre-market trading. Galena Biopharma priced 28 million shares at $0.45 per share.